|
Name |
Methyl nonadecanoate
|
Molecular Formula | C20H40O2 | |
IUPAC Name* |
methyl nonadecanoate
|
|
SMILES |
CCCCCCCCCCCCCCCCCCC(=O)OC
|
|
InChI |
InChI=1S/C20H40O2/c1-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20(21)22-2/h3-19H2,1-2H3
|
|
InChIKey |
BDXAHSJUDUZLDU-UHFFFAOYSA-N
|
|
Synonyms |
METHYL NONADECANOATE; 1731-94-8; Methyl nonadecan-1-oate; Nonadecanoic acid methyl ester; Nonadecanoic acid, methyl ester; methylnonadecanoate; n-Nonadecanoic acid methyl ester; Nonadecanoic acid-methyl ester; 67FQ8VV2L3; UNII-67FQ8VV2L3; EINECS 217-056-9; MFCD00009011; Nonadecanoic acid methyl; AI3-36454; Nonadecanoic acid,methyl ester; SCHEMBL109331; CHEBI:87758; DTXSID40169524; BAA73194; Methyl nonadecanoate, >=98% (GC); s5833; ZINC86046710; AKOS015903908; CS-W004262; HY-W004262; Methyl nonadecanoate, analytical standard; DB-043929; FT-0633802; N0460; H10860; Methyl nonadecanoate, puriss., >=98.5% (GC); J-010888; Q27159902; A25CCD7A-EA11-4124-B88C-A168A5582F47
|
|
CAS | 1731-94-8 | |
PubChem CID | 15610 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 312.5 | ALogp: | 9.5 |
HBD: | 0 | HBA: | 2 |
Rotatable Bonds: | 18 | Lipinski's rule of five: | Rejected |
Polar Surface Area: | 26.3 | Aromatic Rings: | 0 |
Heavy Atoms: | 22 | QED Weighted: | 0.219 |
Caco-2 Permeability: | -4.91 | MDCK Permeability: | 0.00001260 |
Pgp-inhibitor: | 0.002 | Pgp-substrate: | 0.001 |
Human Intestinal Absorption (HIA): | 0.003 | 20% Bioavailability (F20%): | 0.965 |
30% Bioavailability (F30%): | 0.999 |
Blood-Brain-Barrier Penetration (BBB): | 0.145 | Plasma Protein Binding (PPB): | 97.23% |
Volume Distribution (VD): | 2.917 | Fu: | 1.36% |
CYP1A2-inhibitor: | 0.233 | CYP1A2-substrate: | 0.189 |
CYP2C19-inhibitor: | 0.337 | CYP2C19-substrate: | 0.065 |
CYP2C9-inhibitor: | 0.12 | CYP2C9-substrate: | 0.952 |
CYP2D6-inhibitor: | 0.235 | CYP2D6-substrate: | 0.046 |
CYP3A4-inhibitor: | 0.313 | CYP3A4-substrate: | 0.045 |
Clearance (CL): | 4.701 | Half-life (T1/2): | 0.171 |
hERG Blockers: | 0.331 | Human Hepatotoxicity (H-HT): | 0.024 |
Drug-inuced Liver Injury (DILI): | 0.401 | AMES Toxicity: | 0.006 |
Rat Oral Acute Toxicity: | 0.02 | Maximum Recommended Daily Dose: | 0.016 |
Skin Sensitization: | 0.962 | Carcinogencity: | 0.046 |
Eye Corrosion: | 0.95 | Eye Irritation: | 0.958 |
Respiratory Toxicity: | 0.899 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC000474 | 0.955 | D07ILQ | 0.640 | ||||
ENC000280 | 0.952 | D00AOJ | 0.625 | ||||
ENC000496 | 0.905 | D00FGR | 0.551 | ||||
ENC000464 | 0.875 | D0Z5SM | 0.519 | ||||
ENC000271 | 0.857 | D0O1PH | 0.483 | ||||
ENC000258 | 0.826 | D00STJ | 0.451 | ||||
ENC000560 | 0.810 | D05ATI | 0.447 | ||||
ENC000724 | 0.808 | D00MLW | 0.413 | ||||
ENC000575 | 0.783 | D0T9TJ | 0.388 | ||||
ENC001181 | 0.778 | D0P1RL | 0.354 |